SG Americas Securities LLC Acquires 60,249 Shares of Beam Therapeutics Inc. $BEAM

Impact · against what's priced in

BEAM is showing strong positive momentum driven by a massive earnings beat and high analyst price targets ($65-$74) relative to its current price of $24.66. While insider selling by the CEO provides a slight headwind, the significant increase in institutional buying and revenue growth suggests a bullish trend.

BEAM+0.60: No priced-in read yet

SG Americas Securities LLC Acquires 60,249 Shares of Beam Therapeutics Inc. $BEAM

What matters in this story

Amgen (AMGN) Laps the Stock Market: Here's Why

SG Americas Securities LLC Acquires 60,249 Shares of Beam Therapeutics Inc. $BEAM

What matters in this story

Amgen (AMGN) Laps the Stock Market: Here's Why

How each ticker is affected

Connected tickers

Track these names every morning.

Glaukos: The Second J-Code Rewrites The Risk Math

CVS Investigation Initiated: Kahn Swick & Foti, LLC Investigates the Officers and Directors of CVS Health Corporation - CVS

Intuitive Surgical, Inc. (ISRG) Exceeds Market Returns: Some Facts to Consider

Graco Is Too Expensive For Optimism

SG Americas Securities LLC Acquires 60,249 Shares of Beam Therapeutics Inc. $BEAM

What matters in this story

Next reads from the same story arc

Amgen (AMGN) Laps the Stock Market: Here's Why

SG Americas Securities LLC Acquires 60,249 Shares of Beam Therapeutics Inc. $BEAM

What matters in this story

Next reads from the same story arc

Amgen (AMGN) Laps the Stock Market: Here's Why

How each ticker is affected

Connected tickers

Track these names every morning.

Glaukos: The Second J-Code Rewrites The Risk Math

CVS Investigation Initiated: Kahn Swick & Foti, LLC Investigates the Officers and Directors of CVS Health Corporation - CVS

Intuitive Surgical, Inc. (ISRG) Exceeds Market Returns: Some Facts to Consider

Graco Is Too Expensive For Optimism